S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

Autor:	Thomas J. Louie, Richard Nathan, Ian Davis, John Pullman, Shrish Budree, Zain Kassam, Sahil Khanna, Thomas J. Borody, Sarah K. McGill, Robert Orenstein, Najwa El-Nachef, Jeff S. Bullock, Colleen R. Kelly, Michael Silverman, Facg, Ari Grinspan, Jessica R. Allegretti, Monika Fisher, Nicholas W. Van Hise, Darrell S. Pardi, Eugene F. Yen, Susy Hota, Colleen S. Kraft, Misra Bg
Rok vydání:	2021
Předmět:	medicine.medical_specialty Hepatology business.industry Internal medicine Gastroenterology medicine Placebo-controlled study Microbiome C difficile business
Zdroj:	American Journal of Gastroenterology. 116:S63-S64
ISSN:	1572-0241 0002-9270
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4184a6f4c367b36b9ddab8e0ddcb41f8 https://doi.org/10.14309/01.ajg.0000773052.38150.f9 Zobrazit plný text záznamu